Another future direction is therefore to amplify the capacity of this method by incorporating other colitis models within training, such as the 2,4,6-Trinitrobenzenesulfonic acid (TNBS), IL-10 knockout, adoptive cell transfer, and oxazolone models [41]. This evidence concerns the gene IL10 and colitis.